204 related articles for article (PubMed ID: 15213167)
1. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.
Priebe GP; Dean CR; Zaidi T; Meluleni GJ; Coleman FT; Coutinho YS; Noto MJ; Urban TA; Pier GB; Goldberg JB
Infect Immun; 2004 Jul; 72(7):4224-32. PubMed ID: 15213167
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant.
Dean CR; Goldberg JB
FEMS Microbiol Lett; 2002 May; 210(2):277-83. PubMed ID: 12044687
[TBL] [Abstract][Full Text] [Related]
3. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
Zolfaghar I; Evans DJ; Ronaghi R; Fleiszig SM
Infect Immun; 2006 Jul; 74(7):3880-9. PubMed ID: 16790760
[TBL] [Abstract][Full Text] [Related]
4. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.
Augustin DK; Song Y; Baek MS; Sawa Y; Singh G; Taylor B; Rubio-Mills A; Flanagan JL; Wiener-Kronish JP; Lynch SV
J Bacteriol; 2007 Mar; 189(6):2203-9. PubMed ID: 17209027
[TBL] [Abstract][Full Text] [Related]
5. Mesophilic Aeromonas UDP-glucose pyrophosphorylase (GalU) mutants show two types of lipopolysaccharide structures and reduced virulence.
Vilches S; Canals R; Wilhelms M; Saló MT; Knirel YA; Vinogradov E; Merino S; Tomás JM
Microbiology (Reading); 2007 Aug; 153(Pt 8):2393-2404. PubMed ID: 17660404
[TBL] [Abstract][Full Text] [Related]
6. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.
Lee EJ; Cowell BA; Evans DJ; Fleiszig SM
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3892-8. PubMed ID: 12939306
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation.
Nesper J; Lauriano CM; Klose KE; Kapfhammer D; Kraiss A; Reidl J
Infect Immun; 2001 Jan; 69(1):435-45. PubMed ID: 11119535
[TBL] [Abstract][Full Text] [Related]
8. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
Pillar CM; Hazlett LD; Hobden JA
Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
12. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa.
Zaidi TS; Fleiszig SM; Preston MJ; Goldberg JB; Pier GB
Invest Ophthalmol Vis Sci; 1996 May; 37(6):976-86. PubMed ID: 8631641
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
[TBL] [Abstract][Full Text] [Related]
15. Assessment of elastase as a Pseudomonas aeruginosa virulence factor in experimental lung infection in mink.
Elsheikh LE; Kronevi T; Wretlind B; Abaas S; Iglewski BH
Vet Microbiol; 1987 Mar; 13(3):281-9. PubMed ID: 3116751
[TBL] [Abstract][Full Text] [Related]
16. Mutation of retS, encoding a putative hybrid two-component regulatory protein in Pseudomonas aeruginosa, attenuates multiple virulence mechanisms.
Zolfaghar I; Angus AA; Kang PJ; To A; Evans DJ; Fleiszig SM
Microbes Infect; 2005 Oct; 7(13):1305-16. PubMed ID: 16027020
[TBL] [Abstract][Full Text] [Related]
17. The role of the galU gene of uropathogenic Escherichia coli in modulating macrophage TNF-α response.
Meyer C; Hoffmann C; Haas R; Schubert S
Int J Med Microbiol; 2015 Dec; 305(8):893-901. PubMed ID: 26481693
[TBL] [Abstract][Full Text] [Related]
18. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
Shaver CM; Hauser AR
Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
[TBL] [Abstract][Full Text] [Related]
19. Diversity of virulence phenotypes among type III secretion negative Pseudomonas aeruginosa clinical isolates.
Toska J; Sun Y; Carbonell DA; Foster AN; Jacobs MR; Pearlman E; Rietsch A
PLoS One; 2014; 9(1):e86829. PubMed ID: 24466261
[TBL] [Abstract][Full Text] [Related]
20. [Serum sensitivity of Pseudomonas aeruginosa isolated from sputum as a virulence factor in the lower respiratory tract].
Sonoda F; Oishi K; Tanaka H; Hideaki M; Kobayashi S; Nagatake T; Matsumoto K
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jun; 29(6):703-9. PubMed ID: 1910122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
